News
Green tea and lemongrass offer a potent combination for headache relief due to their anti-inflammatory and calming properties ...
US FDA approves Azurity Pharma’s Xifyrm for management of moderate-to-severe pain in adults: Woburn, Massachusetts Thursday, June 12, 2025, 12:00 Hrs [IST] Azurity Pharmaceutica ...
The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...
15h
Arabian Post on MSNBreakthrough Reveals Tylenol Blocks Pain At Its SourceA landmark study from the Hebrew University of Jerusalem challenges long-held beliefs about acetaminophen's mode of action, ...
22h
Study Finds on MSNTylenol’s Superpower Has Little To Do With The Brain, Surprising Study RevealsDespite being one of the most widely used pain relievers on the planet, scientists have had trouble figuring out how ...
We unveil medical developments from Belarusian scientists for the heart, calculating ageing, and identifying geneticsBelarusian ...
The Gallatin County Metro Region, including Gallatin County and Bozeman is accepting applications for funding through the ...
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 15,000,000 units ...
A New Era for Analgesia ~ SAN DIEGO, CA / ACCESS Newswire / June 11, 2025 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results